menu
    • menu
    [{"orgOrder":0,"company":"Avelos Therapeutics","sponsor":"Stassets Investment","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"SOUTH KOREA","productType":"Other Small Molecule","year":"2024","type":"Series B Financing","leadProduct":"AD1208","moa":"Undisclosed","graph1":"Oncology","graph2":"IND Enabling","graph3":"Avelos Therapeutics","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Avelos Therapeutics \/ Stassets Investment","highestDevelopmentStatusID":"5","companyTruncated":"Avelos Therapeutics \/ Stassets Investment"}]

    Find Clinical Drug Pipeline Developments & Deals by Avelos Therapeutics

    Menu

    Avelos Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Avelos Therapeutics

                            South Korea arrow
                            IFT FIRST
                            Not Confirmed

                            Avelos Therapeutics

                            South Korea arrow
                            IFT FIRST
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : AD1208

                            Therapeutic Area : Oncology

                            Study Phase : IND Enabling

                            Sponsor : Stassets Investment

                            Deal Size : $12.3 million

                            Deal Type : Series B Financing

                            DEALS_DEV arrow-down

                            Avelos Therapeutics Announces KRW 17 Billion Series B Funding Round

                            Details : The funding aims to support the Avelos lead product candidate AVS1001, which is being evaluated in the early-stage clinical trials for the treatment of colon cancer and stomach cancer.

                            Product Name : AD1208

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            May 29, 2024

                            Lead Product(s) : AD1208

                            Therapeutic Area : Oncology

                            Highest Development Status : IND Enabling

                            Sponsor : Stassets Investment

                            Deal Size : $12.3 million

                            Deal Type : Series B Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth